Creative Capital Management Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Creative Capital Management Investments’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-88	Closed	-$10.2K	–	245
2023 Q3	$10.2K	Hold	88	–	–	0.01%	155
2023 Q2	$9.05K	Hold	88	–	–	0.01%	151
2023 Q1	$9.6K	Buy	+88	New	+$9.73K	0.01%	162

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Creative Capital Management Investments's HZNP Position: Q4 2023 in Review

Creative Capital Management Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 88 shares — an estimated $10.2K sold.

Creative Capital Management Investments first reported a position in HZNP in Q1 2023 and held it in 3 quarters. The position peaked at $10.2K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Creative Capital Management Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Creative Capital Management Investments sold 88 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $10.2K.
Creative Capital Management Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023 and held it in 3 quarters.
Creative Capital Management Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $10.2K in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Creative Capital Management Investments's 13F filing for Q4 2023, filed 6 Feb 2024.